CanFite Biopharma (CANF)
(Delayed Data from AMEX)
$1.99 USD
-0.08 (-3.86%)
Updated Nov 14, 2024 03:59 PM ET
After-Market: $1.99 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 12/5/24 |
---|---|
Current Quarter | -0.27 |
EPS Last Quarter | NA |
Last EPS Surprise | NA |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.25 |
Next Year | -0.05 |
EPS (TTM) | -1.79 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.30M | 0.30M | 1.00M | 10.00M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 0.30M | 0.30M | 1.00M | 10.00M |
Low Estimate | 0.30M | 0.30M | 1.00M | 10.00M |
Year ago Sales | 0.20M | 0.16M | 0.74M | 1.00M |
Year over Year Growth Est. | 50.00% | 87.50% | 34.59% | 900.00% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.27 | -0.24 | -1.25 | -0.05 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.29 | -0.29 | -1.29 | -1.11 |
High Estimate | -0.27 | -0.24 | -1.25 | -0.05 |
Low Estimate | -0.27 | -0.24 | -1.25 | -0.05 |
Year ago EPS | -0.43 | -0.31 | -1.79 | -1.25 |
Year over Year Growth Est. | 37.21% | 22.58% | 30.17% | 96.00% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 1 | 1 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.27 | -0.24 | -1.25 | -0.05 |
7 Days Ago | -0.29 | -0.29 | -1.29 | -1.11 |
30 Days Ago | -0.29 | -0.29 | -1.29 | -1.11 |
60 Days Ago | -0.29 | -0.29 | -1.29 | -1.11 |
90 Days Ago | -0.29 | -0.29 | -1.29 | -1.11 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.27 | -0.24 | -1.25 | -0.05 |
Zacks Consensus Estimate | -0.27 | -0.24 | -1.25 | -0.05 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | NA | NA | -0.31 | -0.43 | NA |
Estimate | NA | NA | -0.27 | -0.43 | NA |
Difference | NA | NA | -0.04 | 0.00 | -0.02 |
Surprise | NA | NA | -14.81% | 0.00% | -7.41% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more